This study is not yet accepting patients

Feasibility Study of a Remote Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension

a study on Macular Degeneration

Summary

Eligibility
for people ages 55-75 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at UCLA
Dates
study started
study ends around

Description

Summary

The primary goal of the study is to test dietary intervention at glycemic control and carotenoid levels in participants with intermediate age-related macular degeneration.

Official Title

Nonrandomized, Unmasked Feasibility Study of a Remote-based Behavioral Dietary Intervention in Patients With Early to Intermediate AMD: Glucose Lowering for Vision Extension (GLOVE)

Keywords

Age-Related Macular Degeneration, Macular Degeneration, Low glycemic Mediterranean diet behavioral modification

Eligibility

You can join if…

Open to people ages 55-75

  • Diagnosis of early to intermediate AMD with no history of retinal geographic atrophy (cRORA) or exudative disease
  • Eating a diet less healthy than average (Healthy Eating Index [HEI] score <61) based on 3 24-hour dietary recalls
  • Access to a computer or smart phone for use in the behavioral meetings (we will provide loaners for those lacking a smart phone
  • Because the initial questionnaires (ASA24), surveys and informed consent will be on line and in English, only individuals with fluency in English will be included. (They do not need to list English as their primary language.)

You CAN'T join if...

  • HbA1c greater than 6.5%,
  • Diabetes or medications used to treat diabetes or obesity (including GLP1 agonists, metformin, glyburide
  • Use of statins, niacin or other lipid/cholesterol modifying medications
  • Recent cancer (within past 3 years)
  • Other retinal or ocular pathology (other than pseudophakia and/or refractive error (between -8 to +8 diopter spherical equivalence)

Location

  • University of California, Los Angeles
    Los Angeles California 90095 United States

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Stanford University
ID
NCT07605468
Study Type
Interventional
Participants
Expecting 32 study participants
Last Updated